Cargando…
B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009793/ http://dx.doi.org/10.1097/01.HS9.0000829560.21894.ee |
_version_ | 1784687340814336000 |
---|---|
author | Gay, F Berdeja, JG De Stefano, V Hari, P Hooper, B Haltner, A Kumar, S Martin, T Mateos, M-V Moreau, P Rosta, E Samjoo, IA Usmani, SZ Weisel, K Jackson, CC Olyslager, Y Schecter, JM Vogel, M Garrett, A Lee, S Nesheiwat, T Pacaud, L Zhou, C Valluri, S Costa, LJ Lin, Y |
author_facet | Gay, F Berdeja, JG De Stefano, V Hari, P Hooper, B Haltner, A Kumar, S Martin, T Mateos, M-V Moreau, P Rosta, E Samjoo, IA Usmani, SZ Weisel, K Jackson, CC Olyslager, Y Schecter, JM Vogel, M Garrett, A Lee, S Nesheiwat, T Pacaud, L Zhou, C Valluri, S Costa, LJ Lin, Y |
author_sort | Gay, F |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9009793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-90097932022-04-18 B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA Gay, F Berdeja, JG De Stefano, V Hari, P Hooper, B Haltner, A Kumar, S Martin, T Mateos, M-V Moreau, P Rosta, E Samjoo, IA Usmani, SZ Weisel, K Jackson, CC Olyslager, Y Schecter, JM Vogel, M Garrett, A Lee, S Nesheiwat, T Pacaud, L Zhou, C Valluri, S Costa, LJ Lin, Y Hemasphere Best Abstracts - Oral Presentations Lippincott Williams & Wilkins 2022-04-05 /pmc/articles/PMC9009793/ http://dx.doi.org/10.1097/01.HS9.0000829560.21894.ee Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Best Abstracts - Oral Presentations Gay, F Berdeja, JG De Stefano, V Hari, P Hooper, B Haltner, A Kumar, S Martin, T Mateos, M-V Moreau, P Rosta, E Samjoo, IA Usmani, SZ Weisel, K Jackson, CC Olyslager, Y Schecter, JM Vogel, M Garrett, A Lee, S Nesheiwat, T Pacaud, L Zhou, C Valluri, S Costa, LJ Lin, Y B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA |
title | B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA |
title_full | B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA |
title_fullStr | B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA |
title_full_unstemmed | B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA |
title_short | B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA |
title_sort | b05: results from a meta-analysis of ciltacabtagene autoleucel compared to physician’s choice of treatment in patients with relapsed or refractory multiple myeloma |
topic | Best Abstracts - Oral Presentations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009793/ http://dx.doi.org/10.1097/01.HS9.0000829560.21894.ee |
work_keys_str_mv | AT gayf b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT berdejajg b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT destefanov b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT harip b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT hooperb b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT haltnera b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT kumars b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT martint b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT mateosmv b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT moreaup b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT rostae b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT samjooia b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT usmanisz b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT weiselk b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT jacksoncc b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT olyslagery b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT schecterjm b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT vogelm b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT garretta b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT lees b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT nesheiwatt b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT pacaudl b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT zhouc b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT valluris b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT costalj b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma AT liny b05resultsfromametaanalysisofciltacabtageneautoleucelcomparedtophysicianschoiceoftreatmentinpatientswithrelapsedorrefractorymultiplemyeloma |